首页> 外国专利> Intermediate 4 - substituted Pyridine Compound, Process for preparing a Compound, Process for Preparation of substituted Pyridine Intermediate 4 - alquilamino and Procedure for preparing a benzamide Compound

Intermediate 4 - substituted Pyridine Compound, Process for preparing a Compound, Process for Preparation of substituted Pyridine Intermediate 4 - alquilamino and Procedure for preparing a benzamide Compound

机译:中间体4-取代吡啶化合物,化合物的制备方法,中间体4-取代氨基吡啶的制备方法和苯甲酰胺化合物的制备方法

摘要

It provides a favorable 4 - substituted Pyridine Compound of formula (2): for an improved procedure for use in preparation of benzamide Derivatives of formula (1) that are known to be inhibitors of Thrombin (1 (where R1 and R2 independently represent a Group (3) or R1 and R2 ju Form a group or many heterocicloalquilo heterocicloalquenilo C3 - 7Which may optionally be substituted with alkyl group C1 - 6, c1-4 alkoxy, halogen, carboxylic acid or an ester of a carboxylic acid c1-4; R3 represents Hydrogen, halogen, alkyl or alkoxy C1 C1 - 3 - 2; R4, R5 and R6 independently represent Hydrogen or Halogen; R7 represents Hydr u00f3geno C1 - alkyl or cycloalkyl R8 represents Hydrogen; 6, 8 cicloalquenilo C3, C3 - 7Heterocicloalquilo C3 C3 - 7 - 7, heterocicloalquenilo, aryl, heteroaryl groups which are optionally substituted with one or more selected groups of halogen, Hydroxy, alkoxy alkyl C1 CN - 6, 6 - aciloxi C1, C1 - 6, nr9r10, nhcor11, nhso2r12, cor13, co2r14, conr15r16, and so2nhr17, X represents A Link, a C1 - 6 alkyl Chain, or a Chain of alquenilo C3 - 6With optionally one or two Atoms of Nitrogen, Oxygen or Sulfur can be contained in each chain and the chains are optionally substituted with one or more selected groups of halogen, Hydroxy, NS, 6 - alkoxy alkyl C1, C1 - 6 - 6, aciloxi C1, nr9r10, nhcor11, nhso2r12, cor13, CO2R 14, conr15r16 and so2nhr17; R9 - R17 represent Hydrogen, alkyl C1 - 6Or R9 and R10 or R15 and R16 form a ring heterocicloalquilo C3 - 7, or R12 additionally can represent trifluoromethyl
机译:它提供了一种有利的式(2)的4-取代吡啶化合物:用于制备已知为凝血酶抑制剂的式(1)苯甲酰胺衍生物的改进程序(1(其中R1和R2独立代表一个基团(3)或R 1和R 2形成一个基团或许多个杂环氯基杂环氯基C 3-7,其可以任选地被烷基C 1-6,c 1-4烷氧基,卤素,羧酸或羧酸的酯c 1-4取代; R 3代表氢,卤素,烷基或烷氧基C1-C2-3-2; R4,R5和R6独立地代表氢或卤素; R7代表Hydr C1-烷基或环烷基R8代表氢; 6、8环氯喹啉C3,C3-7杂氯喹啉C3 C3-7-7,杂环烷基,芳基,杂芳基,其任选地被一个或多个选定的卤素,羟基,烷氧基烷基取代的基团C1 CN-6、6-6-Aciloxi C1,C1-6,nr9r10,nhcor11,nhso2r12,cor13 ,co2r14,conr15r16和so2nhr17,X代表一个连接,一个C1-6烷基链或Alquenilo C3-6链,每条链中可包含一个或两个氮,氧或硫原子,并且这些链可任选地被一个或多个选定的卤素基团取代,羟基,NS,6-烷氧基烷基C1,C1-6-6,阿西洛西C1,nr9r10,nhcor11,nhso2r12,cor13,CO2R 14,conr15r16和so2nhr17; R 9 -R 17代表氢,烷基C 1-6或R 9和R 10或R 15和R 16形成环杂环氯基C 3-7,或R 12可另外代表三氟甲基

著录项

  • 公开/公告号AR034867A1

    专利类型

  • 公开/公告日2004-03-24

    原文格式PDF

  • 申请/专利权人 GLAXO GROUP LIMITED;

    申请/专利号AR2002P102596

  • 发明设计人

    申请日2002-07-11

  • 分类号C07D413/04;C07D213/74;

  • 国家 AR

  • 入库时间 2022-08-21 23:12:23

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号